ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development
ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a leader in ultra-sensitive immunoassay technologies, today announced a partnership in the development of customized biomarker assay solutions using Alamar’s NULISA™ (Nucleic Acid Linked Immuno-Sandwich Assay) immunoassay platform and ARGO™ HT System. This collaboration aims to provide advanced tools for the detection and quantification of critical biomarkers to support neurological disease therapeutic development.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241027884281/en/
ADx NeuroSciences logo (Graphic: Business Wire)
Under the terms of the partnership, Alamar Biosciences and ADx NeuroSciences will combine their respective expertise to provide tailored assay solutions to meet the specific needs of pharmaceutical companies advancing novel therapeutics for neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS.
"We are excited to partner with ADx NeuroSciences, a recognized leader in the field of neurodegenerative biomarker research," said Dr. Yuling Luo, Chairman and CEO of Alamar Biosciences. "By combining our NULISA platform's ultra-sensitive detection capabilities with ADx’s extensive expertise in neuroscience antibody and assay development, we aim to accelerate the development of biomarker assays that can facilitate the development and approval of disease modifying therapies for neurodegenerative diseases.”
Koen Dewaele, CEO of ADx NeuroSciences, commented, "Our collaboration with Alamar Biosciences marks a significant step forward in our mission to support pharmaceutical companies advancing their therapeutic programs. Every phase in the search for a therapeutic, from preclinical work up to the launch of the ultimate drug, requires specific biomarker tools. By working with various technology platforms, we are able to make our biomarker assays available on the right technology at the right time. By adding the NULISA platform with its remarkable sensitivity to our range of possible platforms, it enforces our capabilities to support our pharma network in their search for tailor-made biomarkers."
This strategic collaboration highlights both companies' commitment to advancing biomarker detection and expanding the possibilities for early diagnosis and treatment of neurodegenerative diseases. By harnessing the power of the NULISA platform, Alamar Biosciences and ADx NeuroSciences aim to deliver cutting-edge solutions that will benefit clinical research and aid in the development of novel therapeutics.
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company’s proprietary NULISA Platform along with the ARGO™ HT System works seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the high sensitivity protein detection technologies on the market today. For more information, please visit alamarbio.com.
About ADx NeuroSciences NV
ADx NeuroSciences is specialized in the research and development of neurodegenerative biomarker tools for diseases such as Alzheimer's and Parkinson's. Its expertise is used by pharmaceutical and diagnostic companies across the world for the conception, development, production, and worldwide commercialization of novel biomarkers, supporting the development of promising drugs, either by monitoring the drug effect or by selecting the right patients at a very early stage of the disease. These assays can be applied to a variety of platforms from research up to IVD use. The company was founded in 2011 and was acquired in 2022 by Fujirebio, a member of H.U. Group Holdings Inc., which is listed on the Tokyo Stock Exchange (TSE: 4544). For more information, please visit www.adxneurosciences.com.
About Fujirebio
Fujirebio, a member of H.U. Group Holdings Inc., is a global leader in the field of high-quality IVD testing with more than 50 years’ accumulated experience in the conception, development, production, and worldwide commercialization of robust IVD products. Fujirebio was the first company to develop and market CSF biomarkers for AD testing, under the Innogenetics brand, over 25 years ago. Fujirebio remains the only company with such a comprehensive line-up of manual and fully automated neurodegenerative disease assays and consistently partners with organizations and clinical experts across the world to develop new pathways for earlier, easier, and more complete neurodegenerative diagnostic tools. For more information, please visit www.fujirebio.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241027884281/en/
Contacts
For media inquiries, please contact:
Alamar Biosciences, Inc. Media Contact:
April Falcone
Alamar Biosciences
afalcone@alamarbio.com
(510) 838-1783
ADx NeuroSciences NV:
Ann De Vos
ADx NeuroSciences
info@adxneurosciences.com
+32 9 329 1486
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Prodapt Announces Agentic Solutions for Autonomous Operations Powered by NVIDIA AI Platform17.6.2025 07:30:00 EEST | Press release
Prodapt, a Gartner-recognized Telecom-Native services and AI integration leader, today announced a new Agentic AI based solution to drive autonomous operations for Telcos, in collaboration with NVIDIA. The solution leverages the NVIDIA AI platform to build and deploy Telco-trained AI Agents that predict, analyze, reason, and simulate to resolve incidents impacting service quality and customer experience. Telcos want to deliver better experiences and cut costs and AI Agents help by accelerating the next transformational leap from traditional BSS/OSS systems. This requires agile AI infrastructure, cutting-edge GenAI platforms, and AI integration skills, to enable scalability as the industry evolves beyond experimentation. As part of its Practical AI strategy, Prodapt has built a range of AI Agents across the Telecom value chain, which are powered by NVIDIA NIM™ and NVIDIA NeMo™ microservices. These agents go beyond simple actions, solving multi-step problem statements to improve operatio
Amazfit Expands Active 2 Lineup with the New Active 2 Square — All the Same Features, Now in a Sleek Square Design17.6.2025 07:01:00 EEST | Press release
Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today announced the launch of the square version of the Amazfit Active 2, a new addition to its fitness smartwatch line that offers the same powerful features and premium experience as the recently launched round Active 2 — now in a modern, square form factor. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250616213563/en/ Amazfit Active 2 Square Same Features. New Shape. Debuting at CES 2025 and featured at Pepcom and ShowStoppers, the Active 2 Square is designed for consumers who prefer a bold, geometric aesthetic without compromising performance, durability, or advanced health and fitness tracking. Featuring a square, 1.75 inch sapphire glass high-definition AMOLED display elegantly encased in a polished stainless-steel frame, the Amazfit Active 2 delivers an optimal visual experience with a peak brightness of 2,
Agileo Automation Announces Future Expansion Of A 2 ECF-SEMI Automation Framework With SEMI EDA Standards17.6.2025 07:00:00 EEST | Press release
CEA LID World Summit –Agileo Automation, a leading provider of control and connectivity solutions for global semiconductor manufacturing equipment, today announced the future expansion of its A2ECF-SEMI automation framework to include SEMI’s EDA (Equipment Data Acquisition) standards suite. This integration that already includes Agil’GEM and Agil’GEM300 will empower OEMs to deliver structured, high-bandwidth data to manufacturing facilities and drive process improvements with artificial intelligence (AI) by leveraging large amounts of reliable, actionable data. EDA standards, built on the legacy of SECS/GEM and GEM300, are transforming equipment communication and enabling high-speed, data-driven manufacturing.As semiconductor fabs become more connected and automated, the ability of OEM equipment to integrate seamlessly and deliver high-quality, structured data has become a competitive differentiator. This press release features multimedia. View the full release here: https://www.busine
Ant International Empowers Partners to Serve Over 15 Million Customers Globally with Intelligent Credit Tech Solutions17.6.2025 04:00:00 EEST | Press release
Through its credit tech solutions, Ant International has enabled financial institutions and fintech companies to extend credit access to over 15 million customers, including micro, small and medium-sized enterprises (MSMEs) in emerging markets, according to Quan Yu, General Manager of Credit Services, Ant International. Ant International is a global leader in digital payments, digitisation and financial technology. Millions of MSMEs and individuals remain underserved due to the lack of collaterals, stable income or credit history. To serve these segments and grow business, financial service providers need intelligent credit tech solutions powered by alternative data and embedded in their existing systems. The Ant Credit Engine, one of the core innovative offerings developed by Ant International, is an intelligent and automated credit engine. It helps financial institutions, fintechs, e-wallets and other qualified lenders such as digital platforms in e-commerce, delivery and ride-hailin
Lattice to Showcase FPGA Innovations at FPGA Conference Europe 202516.6.2025 23:00:00 EEST | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced its exhibition plan for the upcoming FPGA Conference Europe. As part of the event, Lattice Senior Vice President of Research and Development Pravin Desale will deliver an opening speech where he will explore the market dynamics and trends that are positioning low power FPGAs at the forefront of technological advancements. In addition, Lattice will participate in various speaker sessions to showcase how low power FPGAs are driving innovation across multiple sectors. The company will also demonstrate its latest FPGA technology advancements in edge AI, advanced connectivity, robust security, and more. Who: Lattice Semiconductor What / When (GMT+2): July 1 – 3: Lattice Demo Showcase (Exhibition Table #5) Speaker sessions: Day 1 Opening Speech: “Powering the Future – How Low Power FPGAs are Shaping Tomorrow's Tech Landscape” by Pravin Desale, Head of R&D, Lattice Semiconductor Day 1 – 3 Speaker Sessions
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom